Pro Share Advisors LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$3.84 - $9.74 $45,231 - $114,727	-11,779 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$5.12 - $8.19 $2,150 - $3,439	420 Added 3.7%	11,779 $62,000
Q3 2021 Nov 12, 2021	SELL	$6.68 - $9.1 $20,347 - $27,718	-3,046 Reduced 21.15%	11,359 $76,000
Q2 2021 Aug 13, 2021	BUY	$7.82 - $9.23 $13,536 - $15,977	1,731 Added 13.66%	14,405 $123,000
Q1 2021 May 14, 2021	BUY	$8.44 - $12.66 $7,359 - $11,039	872 Added 7.39%	12,674 $112,000

Q4 2020 Feb 09, 2021	BUY	$7.98 - $12.29 $94,179 - $145,046	11,802 New	11,802 $145,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.